PHARMACOTHERAPY OF TYPICAL AND ATYPICAL ANOREXIA NERVOSA IN ADOLESCENT GIRLS WITH OLIGO-AMENORRHEA
https://doi.org/10.21886/2219-8075-2015-3-74-78
Abstract
Purpose: develop optimal treatment of adolescent girls with AN and oligo-amenorrhea depending on the clinical features (typical and atypical HA), as well as the severity of psychopathology.
Materials and Мethods: I group - 22 patients with typical AN, II group - 18 patients with a diagnosis of atypical AN. The age of both groups 16 (18; 14) years. The body mass index I of group - 15,6 (17,5; 11,6), II - 14,55 (17,34; 10,2). Control group - 20 teenage girls. Conducted clinical-psychopathological, experimental psychological research, psychometric scaling.
Results: revealed differences in the treatment of typical and atypical AN, higher efficiency of treatment was found in patients with typical AN.
Summary: the results suggest the need to further study the effects of pharmacological therapies for the development of optimal treatment strategy of adolescent girls with AN and oligo-amenorrhea.
About the Authors
L. M. LevRussian Federation
V. O. Andreeva
Russian Federation
V. G. Zaika
Russian Federation
A. S. Andreev
Russian Federation
N. V. Tkachenko
Russian Federation
K. E. Khoshabi
Russian Federation
References
1. Psychotropic medication use in anorexia nervosa between 1997 and 2009 / P. Fazeli, G. Calder, K. Miller et al. // Int. J. Eat. Disord. – 2012. - Vol.46, №8. P. 970-976.
2. Самочатова, Н.В. Аменорея у больных нервной анорексией / Н.В. Самочатова, А.А. Осипова // Проблемы репродукции. – 2009. – №1. – С.46-51.
3. Ekbom, А. Excess mortality, causes of death and prognostic factors in anorexia nervosa / A. Ekbom, L. Brandt, L. Ekselius // Br. J. Psychiatry – 2009. – Vol.194, №1. – P. 10-17.
4. Актуальные вопросы психотерапии зависимого пищевого поведения / Б.Ю. Приленский, А.В. Приленская, И.И. Федорова, Д.В. Култышев // Медицинская психология в России. – 2009. - №1. – С. 162-168.
5. Приленская, А.В. Клиническая динамика пограничных нервно-психических нарушений при пищевом поведении. / А.В. Приленский // Сибирский вестник психиатрии и наркологии. – 2009. - №3. - С. 61-63.
6. Brewerton, T.D. Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials / T.D. Brewerton // Curr. Psychiatry Rep. 2012. - №14(4). – P. 398-405.
7. What potential role is there for medication treatment in anorexia nervosa? / S.J. Crow, J.E. Mitchell, J.D. Roerig, K. Steffen K. // Int. J. Eat. Disord. - 2009. – Vol. 42, №1. – P. 1–8.
8. Роль нейропептида Y в патогенезе репродуктивных расстройств у пациенток с нервной анорексией / В.О. Андреева, Л.Ю. Шабанова, Е.В. Зинкина, А.А. Андреева // Российский Вестник акушера-гинеколога. – 2008. – Том. 8, № 3. – С. 20-24.
9. Outcome in anorexia nervosa adult patients: a 13-year follow-up in 484 patients. / D. Rigaud, H. Pennacchio, C. Bizeul, V. Reveillard et al. // Diabetes Metab. - 2011. - Vol. 37, №4. – P.305-11.
Review
For citations:
Lev L.M., Andreeva V.O., Zaika V.G., Andreev A.S., Tkachenko N.V., Khoshabi K.E. PHARMACOTHERAPY OF TYPICAL AND ATYPICAL ANOREXIA NERVOSA IN ADOLESCENT GIRLS WITH OLIGO-AMENORRHEA. Medical Herald of the South of Russia. 2015;(3):74-78. (In Russ.) https://doi.org/10.21886/2219-8075-2015-3-74-78